The Impact of Inotuzumab Ozogamicin (InO) Treatment on Brexucabtagene Autoleucel (Brexu-cel) Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Aldoss, I., Roloff, G. W., Advani, A. S., Kopmar, N. E., Lin, C., Dekker, S. E., Gupta, V. K., Jeyakumar, N., O'Connor, T. E., Zhang, A., Miller, K., Dykes, K. C., Ahmed, M., Zambrano, H., Bradshaw, D., Mercadal, S., Schwartz, M., Tracy, S., Dholaria, B., Kubiak, M., Mukherjee, A., Majhail, N., Battiwalla, M., Mountjoy, L., Malik, S. A., Mathews, J., Shaughnessy, P., Logan, A. C., Ladha, A., Yaghmour, G., Stefan, M., Guzowski, C., Hoeg, R. T., Hilal, T., Moore, J., O'Dwyer, K. M., Tsai, S. B., Sasine, J., Solh, M. M., Lee, C. J., Kota, V. K., Koura, D., Veeraputhiran, M., Blunk, B., Leonard, J. T., Oliai, C. H., Bachanova, V., Stock, W., Galal, A., Pullarkat, V., Cassaday, R. D., Shah, B. D., Faramand, R., Muffly, L. S. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-182404

View details for Web of Science ID 001159900800078